The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The effect of PARP inhibition on androgen receptor localization and activity in castration resistant prostate cancer.
 
Emily Nizialek
Other Relationship - AstraZeneca
 
Michael Haffner
No Relationships to Disclose
 
Akshay Bhamidipati
No Relationships to Disclose
 
Srinivasan Yegnasubramanian
Stock and Other Ownership Interests - Brahm Astra Therapeutics; Digital Harmonic
Consulting or Advisory Role - Cepheid
Research Funding - Celgene/Bristol-Myers Squibb (Inst); Cepheid (Inst); Janssen (Inst)
Patents, Royalties, Other Intellectual Property - COMPARE-MS: A novel technique for rapid, sensitive, and accurate detection of DNA methylation; Patent Pending: "Induction of synthetic lethality with epigenetic therapy"; Patent: "Agents for reversing epigenetic silencing of genes"; Patent: "Bisulfite-converted duplexes for the strand-specific detection and quantification of rare mutations" Recipient: You; Patent: "DNA methylation markers for metastatic prostate cancer" Recipient: You